TULSA, Okla. and VANCOUVER, British Columbia, April 12, 2018 -- Jericho Oil Corporation (“Jericho”) (TSX-V:JCO) (OTC PINK:JROOF) announces that all outstanding common share purchase warrants (the "Warrants") expiring on April 13, 2018 have been exercised. A total of 827,900 warrants were exercised at $0.60 per share for proceeds to the Company of $496,740.
About Jericho Oil Corporation
Jericho Oil (www.jerichooil.com) is focused on domestic, liquids-rich unconventional resource plays, located primarily in the Anadarko basin STACK play of Oklahoma. Jericho’s primary business objective is driving long-term shareholder value through the growth of oil and gas production, cash flow and reserves. Jericho has assembled a 55,000 net acre position across Oklahoma, including an interest in 14,000 net acres in the STACK play.
Jericho’s current operations are focused on the oil-prone Meramec and Osage formations in the STACK. The Jericho team applies advanced engineering analyses and enhanced geological techniques to under-developed resource areas.
Based in Vancouver, British Columbia, with operational headquarters in Tulsa, Oklahoma, Jericho trades publicly on the TSX-Venture (TSX-V:JCO) and OTC (OTC PINK:JROOF).
Cautionary Note Regarding Forward-Looking Statements: This news release includes certain "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and Canadian securities laws. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual events and results to differ materially from Jericho's expectations include risks related to the exploration stage of Jericho's project; market fluctuations in prices for securities of exploration stage companies; and uncertainties about the availability of additional financing.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CONTACTS:
Tony Blancato,
Director, Investor Relations
918.986.7616
or
Adam Rabiner,
Director, Corporate Communications
1.800.750.3520
[email protected]


FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
How Marco Pharma International Preserves German Homeopathic Traditions in America
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 



